Latest News

The IDE study aims to evaluate the safety and clinical effectiveness of the PHR® System to address the challenges faced by younger, more active patients.

Our second site for the IDE Study on the Polymotion® Hip Resurfacing device is now live!

IDE Study Launched for Polymotion® Hip Resurfacing Device

A significant milestone in orthopaedic surgery at Rockyview General Hospital in Calgary

​

JointMedica is proud to announce that Ian Bowen, Manufacturing Engineering Manager, has been awarded the company’s first President's Award.

Commercial Team Delivers Expert Training

Ruby Garner, a Medical Engineering student from Cardiff University, visited us for an immersive training day.

JointMedica named the Best Orthopaedic Hip Device Manufacturer 2024 - Midlands!

University of Toronto invited Mr. Ronan Treacy to take part in the prestigious Grand Rounds

First Polymotion Hip Resurfacing (PHR®)* procedure performed in Ontario, Canada

JointMedica Key Leadership Appointments and Organisational Changes.

Dr. Sharat Kusuma, representing JointMedica, journeyed to New Zealand to oversee the first in-patient surgeries featuring the innovative Polymotion® Hip Resurfacing

Avi Pelossof Appointed Executive Chairman of JointMedica, Spearheading Innovation in Medical Technology

The NHS marked 75 years of service. In honour of this, ITVX shared a newsreel featuring key milestones in healthcare and technology advances from the Midlands

The largest retrospective analysis of hip resurfacing arthroplasty (HRA) specifically for patients aged under 40 years...

Running Following Hip Arthroplasty by Harrington, Colin J et al. 2023

Steve Meakins alongside 39 team members, raised over £15,000 for Ashfield Trust by taking on this years Tough Mudder Challenge.

Impact loads and strength reach interlimb symmetry at 6 months post- Hip Resurfacing Arthroplasty (HRA).

National Finalist Medilink UK Health Care Business Award 2023

RHA caused significantly lower blood loss and similar satisfactory functional results, with no significant difference in metal ion levels.

Resurfacing hip arthroplasty better preserves a normal gait pattern at increasing walking speeds compared to total hip arthroplasty

Hip resurfacing has been highlighted as one of the most interesting trends and developments in the field of arthroplasty.

Winners of the Medilink Midlands Business Awards 2023 announced

For the final step of last year’s initial expansion phase, JointMedica welcomed the arrival of a second Brother Speedio CNC Machine.

JointMedica has been shortlisted for the “Innovation” category which recognises the development of innovative technology.

Dr. Jim MacKenzie of Calgary Orthopaedics Celebrates 20 years of Hip Resurfacing

The 1962 surgery was the first total hip replacement to be performed using low friction prostheses at Wrightington

A meta-analysis assessing time for return for sport following hip resurfacing

Complications and mid to long term outcomes for hip resurfacing versus total hip replacement: a systematic review and meta-analysis’

We are excited and delighted to announce we have been awarded Medical Technology Manufacturers of the Year!

Birmingham Hip Resurfacing: the whole story. Callum McBryde, Ronan Treacy, Derek McMinn and Roger Ashton teamed together to discuss the background behind the development of the BHR and the future of hip resurfacing.

Supported by JointMedica since 2018, Lewis Woolin has been investigating our new and unique concepts in Total Hip Replacement (THR) technologies

Flexible Working whilst studying for a PhD - Gustavo has now been with JointMedica for almost two months now, so we decided to take the opportunity to find out how he has settled in.

On behalf of Innovate UK, CPI and ABHI have developed the Health Technology Regulatory and Innovation Programme to support small and medium-sized (SME) businesses to navigate the complex and ever-changing HealthTech regulatory landscape.

JointMedica and Exactech unite for a three-day welcome event.

JointMedica awarded “Most Innovative Orthopaedic Device Development Firm 2022 - UK.”

FDA Breakthrough Device Designation for JointMedica's Polymotion® Hip Resurfacing System

We took the opportunity to speak to Mr Ronan Treacy, co-inventor with Prof Derek McMinn, MD FRCS of the Birmingham Hip Resurfacing™ (BHR™)

JointMedica’s recent shareholding acquisition by Exactech is recognised globally and by the local community